H. Gardarsdottir, E. Heerdink, and A. Egberts. Pharmacoepidemiology and drug safety, 15 (5):
338-43(May 2006)4368<br/>PUBM: Print; JID: 9208369; 0 (Antidepressive Agents); ppublish;<br/>Mesures de freqüència.
T. Stürmer, M. Funk, C. Poole, and M. Brookhart. Epidemiology (Cambridge, Mass.), 22 (3):
298-301(May 2011)6101<br/>Miscellaneous; NLM Journal Code: a2t, 9009644;<br/>CER; Databases.
V. Kiri, and G. Mackenzie. American journal of epidemiology, 170 (5):
667-8; author reply 668-9(September 2009)5589<m:linebreak></m:linebreak>JID: 7910653; CON: Am J Epidemiol. 2008 Feb 15;167(4):492-9. PMID: 18056625; 2009/07/31 aheadofprint; ppublish;<m:linebreak></m:linebreak>Mesures d'associació; Immortal time bias.
C. Hebert, J. Delaney, B. Hemmelgarn, L. Lévesque, and S. Suissa. Pharmacoepidemiology and drug safety, 16 (8):
845-9(August 2007)4654<m:linebreak></m:linebreak>LR: 20081121; JID: 9208369; 0 (Central Nervous System Agents); 12794-10-4 (Benzodiazepines); CIN: Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):850-3. PMID: 17636552; ppublish;<m:linebreak></m:linebreak>Mesures d'associació.
S. Suissa, E. Moodie, and S. Dell'Aniello. Pharmacoepidemiology and drug safety, 26 (4):
459-468(April 2017)Propensity score; CER; New-user designs; Diabetis.